Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis

PHASE3CompletedINTERVENTIONAL
Enrollment

455

Participants

Timeline

Start Date

June 7, 2019

Primary Completion Date

March 29, 2020

Study Completion Date

April 29, 2020

Conditions
Candida Vulvovaginitis
Interventions
DRUG

Ibrexafungerp

Ibrexafungerp 300mg BID for one day

DRUG

Placebo

Matching Placebo

Trial Locations (41)

1407

Medical Center Excelsior OOD - PPDS, Sofia

1618

Diagnostic Consultative CTR - XX - Sofia - EOOD, Sofia

1680

Medical center Vip Clinic OOD, Sofia

2000

Multiprofile Hospital for Active Treatment - Samokov EOOD, Samokov

2600

Medical Center Asklepii OOD, Dupnitsa

2700

MHAT Puls AD - PPDS, Blagoevgrad

3400

MHAT Stamen Iliev AD, Montana

3600

Multiprofile Hospital for Active Treatment- Sveti Nikolay Chudotvoretz - LOM EOOD, Lom

4000

Multiprofile Hospital for Active Treatment Trimontsium OOD, Plovdiv

4230

Multiprofile Hospital for Active Treatment -Asenovgrad EOOD, Asenovgrad

4400

Multiprofile Hospital For Active Treatment - Pazardzhik AD, Pazardzhik

4700

Multiprofile Hospital For Active Treatment - Dr. Bratan Shukerov AD, Smolyan

5000

Medical Center Medica Plus OOD, Veliko Tarnovo

5100

Multiprofile Hospital for Active Treatment Sv. Ivan Rilski - Gorna Oryahovitsa EOOD, Gorna Oryahovitsa

5300

Diagnostic-Consultative Center I-Gabrovo EOOD, Gabrovo

Multiprofile Hospital For Active Treatment Dr Tota Venkova, Gabrovo

5400

Medical Center-1-Sevlievo EOOD, Sevlievo

5500

Multiprofile Hospital for Active Treatment - Prof. Dr. Paraskev Stoyanov AD, Lovech

6200

Multiprofile Hospital for Active Treatment - Chirpan EOOD, Chirpan

9700

Multiprofile Hospital for Active Treatment Shumen, Shumen

16507

Obstetrics and Gynecology Associates of Erie, PC, Erie

19107

Planned Parenthood Southeastern Pennsylvania The Elizabeth Blackwell Health Center, Philadelphia

28304

Carolina Institute for Clinical Research - M3 Wake Research, Fayetteville

29910

Fellows Research Alliance Inc, Bluffton

30328

Mount Vernon Clinical Research, LLC, Sandy Springs

31406

Fellows Research Alliance Inc, Savannah

33016

New Generation Medical Research, Hialeah

33161

Healthcare Clinical Data Inc, North Miami

33409

CCT LLC - A VitaLink Company- PPDS, West Palm Beach

34239

Physician Care Clinical Research LLC, Sarasota

37404

Chattanooga Medical Research Inc, Chattanooga

63033

North County Health Center, Planned Parenthood of the St. Louis Region and Southwest Missouri, Florissant

70072

Praetorian Pharmaceutical Research, LLC, Marrero

75062

Brownstone Clinical Trials, LLC, Irving

76104

Signature GYN Services, PLLC, Fort Worth

80228

Red Rocks OBGYN, Lakewood

83404

Rosemark Women Care Specialists, Idaho Falls

85209

Mesa OB-GYN, Mesa

89123

Clinical Research Center Of Nevada, Las Vegas

06511

Planned Parenthood Southern New England, New Haven

07601

Planned Parenthood North Central Southern New Jersey (PPNCSNJ), Hackensack

All Listed Sponsors
lead

Scynexis, Inc.

INDUSTRY

NCT03987620 - Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis | Biotech Hunter | Biotech Hunter